Natco Pharma

Rediff.com » News » Natco Pharma

News for Natco Pharma

Business

Mid, small-caps outperform in four years of Narendra Modi government

Analysts attribute this outperformance to the government's proactive economic reform measures Illustration: Uttam Ghosh/Rediff.com Mid-and small-cap indices have outperformed large-caps in the......

5 cos that bucked the note ban gloom

V-Mart, Manaksia, Whirlpool Global and few other companies posted better third-quarter results. This column celebrates companies that defied the demonetisation gloom (‘there will be blood on......

India's FDI during Apr-Feb jumps to $37.53 billion

Services attracted the most FDI during the first eleven months period of 2015-16. Foreign direct investment (FDI) in India increased to $37.53 billion during April-February period of the last......

Bears grip Sensex in FY16; investors poorer by Rs 7 lakh crore

Investor wealth too fell by nearly Rs 7 lakh crore during 2015-16 or over Rs 2,700 crore per trading session. In its worst show in four fiscals, the market benchmark Sensex on Thursday ended......

US Fed rate hike boosts Sensex by 309 points; Nifty ends near 7,850

Index heavyweight RIL surged 3% to end above Rs 1,000 mark while IT majors were also the top gainers. Benchmark share indices gained for the fourth straight session tracking a rally in global......

Web results for Natco Pharma

Natco rolls out Baricitinib ahead of approval for patent waiver

Even as it has filed for a compulsory licence for Covid-19 drug Baricitinib in India, Natco Pharma has already begun rolling out its generic... ...

https://timesofindia.indiatimes.com/city/hyderabad/natco-rolls-out-baricitinib-ahead-of-approval-for-patent-waiver/articleshow/82442841.cms

Indian Indices End Flat; Metal and Smallcap Stocks Outperform

Posted by Equitymaster Indian share markets witnessed volatile trading activity throughout the day today and ended on a flat note. Benchmark... ...

http://feeds.equitymaster.com/~r/TodaysMarket/~3/vy2yoBQzQsM/tm.asp

Natco Pharma Gains On Getting Emergency Use Approval Of COVID-19 Drug

Shares of the Hyderabad-based Natco Pharma gained as much as 4.27 per cent to hit an intraday high of Rs 935 after it received emergency use... ...

https://www.ndtv.com/business/covid-19-medicine-news-natco-pharma-gains-over-4-on-getting-emergency-use-approval-of-covid-19-medicine-2426985

Delhi-based lawyers team up to crowd-source money for makeshift Covid hospital

The group that includes Vaibhav Kakkar of L&L partners and Karan Chandhiok of Chandhiok and Mahajan has roped in former Natco Pharma executive CV... ...

https://economictimes.indiatimes.com/news/india/delhi-based-lawyers-team-up-to-crowd-source-money-for-makeshift-covid-hospital/articleshow/82357861.cms

MidCap stocks advance; Natco Pharma leaps 7%

Out of the 101 stocks in the index, 53 advanced while 46 declined and 2 stocks remained unchanged. INSIGHTS Read Stock Insights by ET for a quick... ...

https://economictimes.indiatimes.com/markets/stocks/news/stock-market-update-midcap-stocks-advance-natco-pharma-leaps-7/articleshow/81967691.cms

See All